Reserach canakinumab trial UTHealth joins trial of arthritis drug’s effect on COVID-19-induced cytokine storm

A drug is being studied for its effectiveness in treating a type of severe immune overreaction seen in patients with COVID-19-induced pneumonia by researchers McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital. The Phase III, […]


Study to test efficacy of injectable HIV prevention drug

The HIV Prevention Trials Network, which includes McGovern Medical School, has launched a study to evaluate whether a new injectable medication can work as well as an existing oral pill to safely protect against HIV among men who have sex with men and transgender women who have sex with men.